Skip to main content

NCT01497119 - A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study of JNJ-39758979 in Adult Japanese Subjects with Moderate Atopic Dermatitis

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Study of JNJ-39758979 in Adult Japanese Subjects with Moderate Atopic Dermatitis


CSR Summary

Not Yet Available


Data Specification

Not Available


Annotated CRF

Available upon data request approval

Product Info

Generic Name
Toreforant
Product Name
Therapeutic Area
Immune System Diseases
Enrollment
88
% Female
32.2%
% White
N/A
Product Class
Sponsor Protocol Number
39758979ADM2001
Data Partner
Johnson & Johnson
Condition Studied
Dermatitis, Atopic
Mean/Median Age (Years)
30.7

Supporting Documentation

Clinical Study Report
Collected Datasets
Annotated Case Report Form
Protocol with Amendments
Statistical Analysis Plan
Study Phase 
2

Disclaimer

Clinical study data provided through this site do not replace the official labeling of a given drug product, which presents benefits and risks of the product for approved use(s). Before prescribing any product, health care professionals should consult the current prescribing information approved in their country. Patients seeking information may consult with their health care professional about the product, for which health authority approved written patient information may be available.